Globus Medical Inc (GMED) stock
GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3044% below fair value
$68.60−1.93 (-2.74%)
Close on Nov 19, 2026Market cap $9.21BP/E 17.5Yield –
Globus Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Globus Medical's revenue for the twelve months ending Jun 30, 2026 was $3.14B, up 19.7% year over year. For fiscal 2025 it was $2.94B, up 16.7% from the year before. Over ten years it grew 18.4% a year on average. The highest annual figure on record is $2.94B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.94B | +16.7% |
| FY2024 | Dec 31, 2024 | $2.52B | +60.6% |
| FY2023 | Dec 31, 2023 | $1.57B | +53.3% |
| FY2022 | Dec 31, 2022 | $1.02B | +6.8% |
| FY2021 | Dec 31, 2021 | $958.10M | +21.4% |
| FY2020 | Dec 31, 2020 | $789.04M | +0.5% |
| FY2019 | Dec 31, 2019 | $785.37M | +10.2% |
| FY2018 | Dec 31, 2018 | $712.97M | +12.1% |
| FY2017 | Dec 31, 2017 | $635.98M | +12.8% |
| FY2016 | Dec 31, 2016 | $563.99M | +3.5% |
| FY2015 | Dec 31, 2015 | $544.75M | +14.8% |
| FY2014 | Dec 31, 2014 | $474.37M | +9.2% |
| FY2013 | Dec 31, 2013 | $434.46M | +12.6% |
| FY2012 | Dec 31, 2012 | $385.99M | +16.4% |
| FY2011 | Dec 31, 2011 | $331.48M | +15.0% |
| FY2010 | Dec 31, 2010 | $288.20M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $789.61M | +5.9% |
| Q1 FY2026 | Mar 31, 2026 | $759.85M | +27.0% |
| Q4 FY2025 | Dec 31, 2025 | $826.42M | +25.7% |
| Q3 FY2025 | Sep 30, 2025 | $769.05M | +22.9% |
| Q2 FY2025 | Jun 30, 2025 | $745.34M | +18.4% |
| Q1 FY2025 | Mar 31, 2025 | $598.12M | -1.4% |
| Q4 FY2024 | Dec 31, 2024 | $657.29M | +6.6% |
| Q3 FY2024 | Sep 30, 2024 | $625.71M | +63.1% |
| Q2 FY2024 | Jun 30, 2024 | $629.69M | +115.9% |
| Q1 FY2024 | Mar 31, 2024 | $606.67M | +119.3% |
| Q4 FY2023 | Dec 31, 2023 | $616.53M | +124.6% |
| Q3 FY2023 | Sep 30, 2023 | $383.64M | +51.0% |
| Q2 FY2023 | Jun 30, 2023 | $291.62M | +10.6% |
| Q1 FY2023 | Mar 31, 2023 | $276.69M | +20.0% |
| Q4 FY2022 | Dec 31, 2022 | $274.50M | +9.8% |
| Q3 FY2022 | Sep 30, 2022 | $254.15M | +10.6% |
| Q2 FY2022 | Jun 30, 2022 | $263.65M | +5.0% |
| Q1 FY2022 | Mar 31, 2022 | $230.55M | +1.4% |
| Q4 FY2021 | Dec 31, 2021 | $250.02M | +7.1% |
| Q3 FY2021 | Sep 30, 2021 | $229.72M | +6.3% |
| Q2 FY2021 | Jun 30, 2021 | $251.02M | +68.6% |
| Q1 FY2021 | Mar 31, 2021 | $227.34M | +19.3% |
| Q4 FY2020 | Dec 31, 2020 | $233.45M | +10.3% |
| Q3 FY2020 | Sep 30, 2020 | $216.10M | +10.1% |
| Q2 FY2020 | Jun 30, 2020 | $148.92M | -23.4% |
| Q1 FY2020 | Mar 31, 2020 | $190.58M | +4.2% |
| Q4 FY2019 | Dec 31, 2019 | $211.67M | +8.0% |
| Q3 FY2019 | Sep 30, 2019 | $196.22M | +15.9% |
| Q2 FY2019 | Jun 30, 2019 | $194.54M | +12.2% |
| Q1 FY2019 | Mar 31, 2019 | $182.95M | +4.9% |
| Q4 FY2018 | Dec 31, 2018 | $195.94M | +11.3% |
| Q3 FY2018 | Sep 30, 2018 | $169.24M | +11.5% |
| Q2 FY2018 | Jun 30, 2018 | $173.38M | +13.8% |
| Q1 FY2018 | Mar 31, 2018 | $174.41M | +11.9% |
| Q4 FY2017 | Dec 31, 2017 | $176.03M | +16.1% |
| Q3 FY2017 | Sep 30, 2017 | $151.74M | +11.9% |
| Q2 FY2017 | Jun 30, 2017 | $152.39M | – |
| Q1 FY2017 | Mar 31, 2017 | $155.81M | – |
| Q4 FY2016 | Dec 31, 2016 | $151.59M | – |
| Q3 FY2016 | Sep 30, 2016 | $135.65M | – |
See a number that looks wrong?